We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

45 hedge funds and large institutions have $3.76M invested in Summit Therapeutics in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 5

31% more capital invested

Capital invested by funds: $2.88M → $3.76M (+$883K)

0% more funds holding

Funds holding: 45 → 45 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

7.05% less ownership

Funds ownership: 8.64% → 1.59% (-7.1%)

Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
5
Closed
11
Calls
$94K
Puts
–
Net Calls
+$94K
Net Calls Change
+$37K

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$305K
2
Morgan Stanley
Morgan Stanley
New York
+$161K
3
Marshall Wace
Marshall Wace
United Kingdom
+$159K
4
BlackRock
BlackRock
New York
+$134K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$65.7K

Top Sellers

Rank Fund Capital Flow
1
AGM
Alpine Global Management
New York
-$300K
2
E
Ergoteles
New York
-$101K
3
BFM
Boothbay Fund Management
New York
-$82K
4
Citadel Advisors
Citadel Advisors
Florida
-$64.2K
5
Renaissance Technologies
Renaissance Technologies
New York
-$49K
Name Holding Trade Value Shares
Change 		Change in
Stake
VW
26
Vance Wealth
California
$16K – – –
JP Morgan Chase
27
JP Morgan Chase
New York
$15K +$8.21K +7,257 +141%
TRCT
28
Tower Research Capital (TRC)
New York
$14K +$2.29K +2,028 +22%
CAPTRUST Financial Advisors
29
CAPTRUST Financial Advisors
North Carolina
$13K -$226 -200 -2%
EW
30
Evoke Wealth
California
$10K +$3.39K +3,000 +60%
OCM
31
Osterweis Capital Management
California
$6K +$5.66K +5,000 New
National Bank of Canada
32
National Bank of Canada
Quebec, Canada
$4K – – –
WAM
33
Worth Asset Management
Texas
$4K +$2.26K +2,000 +200%
ATC
34
Adirondack Trust Company
New York
$3K – – –
Citigroup
35
Citigroup
New York
$3K +$938 +829 +48%
TCWA
36
Ten Capital Wealth Advisors
Washington
$2K – – –
Barclays
37
Barclays
United Kingdom
$2K +$1.09K +961 +85%
Bank of America
38
Bank of America
North Carolina
$2K +$1.67K +1,478 +717%
CUAMC
39
China Universal Asset Management Company
China
$2K +$2.13K +1,885 New
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$1.38K +$1.31K +1,159 New
HI
41
Harbour Investments
Wisconsin
$1K – – –
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$35 +$32.2K +28,500 New
PCH
43
Polar Capital Holdings
United Kingdom
– -$5.6K -5,599,407 Closed
AGM
44
Alpine Global Management
New York
– -$300K -300,000 Closed
E
45
Ergoteles
New York
– -$101K -100,722 Closed
BFM
46
Boothbay Fund Management
New York
– -$82K -81,559 Closed
Citadel Advisors
47
Citadel Advisors
Florida
– -$64.2K -56,743 Closed
Renaissance Technologies
48
Renaissance Technologies
New York
– -$49K -49,118 Closed
YIH
49
Y-Intercept (HK)
Hong Kong
– -$10K -10,355 Closed
Simplex Trading
50
Simplex Trading
Illinois
– -$71 -63 Closed
1
2

SMMT Hedge Fund Activity: Q3 2022 in Review

45 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q3 2022, worth a combined $3.76M — up 31% from $2.88M a quarter earlier.

Fund positioning in SMMT was balanced in Q3 2022: 11 funds opened new positions, 11 closed out, 15 added to existing stakes and 5 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $305K. The largest seller was Alpine Global Management, exiting entirely with an estimated $300K sold.

  • 45 institutional investors held Summit Therapeutics (SMMT) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $3.76M of Summit Therapeutics stock for Q3 2022, up 31% quarter-over-quarter.
  • 11 funds opened new Summit Therapeutics positions in Q3 2022 and 11 closed out, a net change of 0 holders.
  • The largest Summit Therapeutics buyer in Q3 2022 was Geode Capital Management, an estimated $305K added.
  • The largest Summit Therapeutics seller in Q3 2022 was Alpine Global Management, an estimated $300K sold.

Based on aggregated 13F filings for Q3 2022.